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Summary
The	objective	of	this	study	was	to	evaluate	the	effects	of	equine	chorionic	gonadotropin	(eCG)	
on	various	characteristics	associated	with	an	effective	timed	artificial	insemination	(AI)	pro-
tocol	in	lactating	dairy	cows.	Cows	(n	=	121)	in	a	single	herd	were	treated	with	2	injections	of	
prostaglandin	F2α	(PGF2α)	14	days	apart	(Presynch),	with	the	second	injection	administered	
11	days	before	the	onset	of	a	timed	AI	protocol.	Cows	received	either	saline	or	400	IU	eCG	
concurrent	with	the	PGF2α	injection	of	the	Ovsynch	protocol	(injection	of	gonadotropin-
releasing	hormone	or	GnRH,	7	days	before	and	48	to	56	hours	after	PGF2α	with	insemination	
occurring	12	to	16	hours	after	the	second	GnRH	injection).	Blood	samples	were	collected	
during	the	study	to	monitor	serum	changes	in	progesterone	and	estradiol	in	order	to	determine	
if	eCG	would	facilitate	increased	estrual	activity,	improved	ovulatory	response,	and	enhanced	
postovulatory	luteal	function.	Administration	of	eCG	tended	to	increase	the	number	of	corpo-
ra	lutea	(CL)	and	on	days	9	and	16	after	PGF2α,	corresponding	to	days	6	and	13	postovulation,	
but	the	volume	of	the	luteal	tissue	was	less	than	that	in	the	control.	Timed	AI	pregnancy	rates	
did	not	differ	between	eCG	(36.9%)	and	control	cows	(41.8%).	We	concluded	that	use	of	eCG	
provided	no	profertility	advantages	to	dairy	cattle	when	programmed	for	a	timed	insemination	
at	first	service.
Key words:	corpus	luteum,	equine	chorionic	gonadotropin,	follicle,	progesterone,	timed	artifi-
cial	insemination	(AI)
Introduction
Cows	inseminated	at	first	service	after	detected	estrus	have	better	conception	rates	than	those	
inseminated	by	appointment	in	an	ovulation-synchronization	program	(40.7	vs.	33.5%;	Steven-
son	and	Phatak,	Dairy	Research	2009,	Report	of	Progress	1021,	pp.	56-62),	but	not	as	good	as	
cows	in	estrus	at	the	timed	artificial	insemination	(AI;	51.8%).	Earlier	work	demonstrated	that	
when	estradiol	cypionate	was	administered	as	part	of	a	timed	AI	program,	pregnancy	outcomes	
tended	to	be	improved.	Because	dairy	cows	have	greater	rates	of	metabolism	of	steroids	and	pro-
duce	large	quantities	of	milk,	their	circulating	concentrations	of	progesterone	and	estradiol	are	
less	in	comparison	with	nonlactating	heifers	despite	having	larger	corpora	lutea	(CL)	and	larger	
follicles,	respectively.	It	seems	that	some	lactating	dairy	cows	lack	sufficient	serum	concentra-
tions	of	estradiol	to	support	and	facilitate	strong	estrual	activity.
Equine	chorionic	gonadotropin	(eCG)	is	a	member	of	the	glycoprotein	family,	which	includes	
follicle	stimulating	hormone	(FSH)	and	luteinizing	hormone	(LH).	It	is	secreted	by	the	tropho-
blast	cells	of	the	chorionic	girdle	in	the	pregnant	mare	beginning	approximately	at	37	days	of	
gestation.	In	the	mare,	eCG	elicits	a	similar	response	to	that	of	LH.	In	contrast,	in	other	species,	
eCG	acts	like	FSH.	The	FSH	properties	of	eCG	have	led	to	its	use	as	an	exogenous	hormone	
preparation	for	stimulation	of	follicular	growth	and	superovulation	in	farm	animals.
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Administration	of	eCG	has	been	shown	to	increase	the	diameter	of	the	preovulatory	follicle,	
thus	suggesting	the	potential	for	increasing	circulating	estradiol	concentrations	and	more	
estrual	activity.	Despite	a	similar-sized	preovulatory	follicles	and	CL,	administration	of	eCG	in-
creased	circulating	progesterone	concentrations	in	cross-breed	lactating	beef	cows	and	Holstein	
dairy	cows.	Equine	CG	may	serve	as	an	exogenous	treatment	to	increase	plasma	concentrations	
of	progesterone	and	estradiol,	while	stimulating	estrual	activity.
The	objective	of	this	study	was	to	evaluate	the	effects	of	eCG	administration	on	preovulatory	
follicle	diameter,	circulating	estradiol	and	progesterone	concentrations,	CL	diameter,	estrous	
activity,	and	pregnancy	rates	in	lactating	dairy	cows	whose	ovulation	is	synchronized	before	first	
service.
Experimental Procedures
Lactating	Holstein	cows	(72	multiparous	and	49	primiparous)	from	the	Kansas	State	Uni-
versity	Dairy	Teaching	and	Research	Center	were	enrolled	in	the	study.	Cows	were	housed	in	
covered	free	stalls	and	fed	twice	daily	a	total	mixed	ration	(TMR)	calculated	to	meet	or	exceed	
the	nutrient	requirements	for	a	lactating	Holstein	cow	producing	110	lb	of	milk	with	3.5%	
milk	fat.	The	diet	consisted	of	corn	silage,	sweet	bran,	cracked	corn,	alfalfa	hay,	whole	cotton-
seed,	soybean	meal,	vitamins,	and	minerals.	Seventeen	breeding	clusters	were	formed	every	14	
days	as	cows	and	heifers	calved.	Cows	were	blocked	by	lactation	number	and	days	in	milk,	and	
assigned	randomly	to	2	treatments	(Figure	1).	Body	condition	scores	(BCS;	1=thin	and	5=fat)	
were	assigned	on	day	–7	for	each	cow.	Inseminations	occurred	between	April	and	November	
2009.	Cows	were	assigned	to	treatments	at	random	stages	of	the	estrous	cycle	and	administered	
2	PGF2α	injections	(Presynch;	2	mL	Estrumate,	Schering-Plough	Animal	Health,	Union,	NJ;	5	
mL	Lutalyse,	Pharmacia	Animal	Health,	New	York,	NY)	injections	14	days	apart	followed	by	a	
timed	AI	protocol	(Ovsynch).	The	Ovsynch	protocol	consisted	of	2	injections	of	100	μg	gonad-
otropin-releasing	hormone	(GnRH;	Fertagyl,	Intervet,	Millsboro,	DE)	9	days	apart	with	a	25	
mg	PGF2α	injection	administered	48	hours	before	a	second	injection	of	GnRH.	Cows	received	
either	400	IU	eCG	(Novormon	5000,	Vetrepharm	Canada	Inc.,	London,	ON;	Pregnecol	6000,	
Bioniche,	Belleville,	ON)	concurrent	with	PGF2α	or	no	further	treatment	(control).	Cows	were	
inseminated	72	hours	after	PGF2α	(16	hours	after	the	second	GnRH	injection).	Pregnancy	was	
initially	diagnosed	at	33	days	post-AI	and	reconfirmed	at	61	days	by	transrectal	ultrasonogra-
phy.	Pregnancy	loss	was	calculated	between	the	2	pregnancy	diagnoses.
All	cows	were	fitted	with	HeatWatch	transmitters	(Cow	Chips	LLC,	Denver,	CO)	on	day	–7	
to	quantify	standing	estrus	and	characteristics	of	estrus	during	the	96-hour	period	encompass-
ing	the	breeding	week	(post-PGF2α	injection).	Transmitter	function	was	tested	on	day	–7	and	0.	
Cows	were	moved	into	a	dirt	lot	twice	daily	for	30	minutes	during	the	breeding	week	for	visual	
detection	of	estrus	and	to	aid	in	expression	of	estrous	activity.	Cows	were	considered	to	be	in	
standing	estrus	when	2	mounts	of	2	seconds	or	longer	in	duration	within	a	24	hour	period	were	
recorded	by	the	HeatWatch	system.
Ovaries	of	all	cows	were	examined	via	transrectal	ultrasonography	using	an	Aloka	500V	ultra-
sound	scanner	equipped	with	5.0	MHz	linear	probe	to	determine	the	structures	present	in	each	
ovary	on	days	–7,	0,	2,	4,	9,	and	16.	A	structural	map	of	each	ovary	was	drawn	with	the	posi-
tion	and	diameter	of	follicles	≥5	mm	in	diameter	and	each	CL,	which	allowed	for	evaluation	of	
visual	luteolysis	and	ovulatory	response	to	both	GnRH	injections	(days	–7	and	4),	preovulatory	
follicle	diameter,	and	CL	diameters	on	days	9	and	16.	Follicle	diameter	was	determined	by	av-
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eraging	the	measurements	of	follicular	width	and	length	taken	at	the	widest	point	and	perpen-
dicular	to	the	first	measurement	using	the	internal	calipers	of	the	Aloka	500V.	Ovulation	on	
day	4	was	defined	as	disappearance	of	one	or	more	follicles	≥8	mm	in	diameter	from	an	ovary,	
which	a	follicle	had	been	recorded	on	the	previous	scan	of	that	ovary,	followed	by	the	formation	
of	a	CL	(Figure	1).
Blood	was	sampled	from	all	cows	by	puncture	of	the	coccygeal	vein	or	artery	into	evacuated	
tubes	(BD	Vacutainer,	Franklin	Lakes,	NJ).	Blood	samples	were	collected	days	–7,	0,	2,	4,	9,	
and	16	for	progesterone	assay.	At	pregnancy	diagnosis,	on	days	33	and	61,	blood	samples	also	
were	collected	from	pregnant	cows	for	later	progesterone	assay.	Additional	blood	samples	were	
collected	every	24	hours	from	days	0	to	3	for	estradiol	assay.	Samples	were	immediately	cooled	
and	stored	at	5°C	for	16	hours.	Blood	tubes	were	centrifuged	at	1,000	x	g	for	15	minutes	in	a	
refrigerated	centrifuge	at	5°C	for	serum	separation	and	harvest.	Serum	samples	were	frozen	and	
stored	at	−20°C	until	assayed	for	progesterone	and	estradiol	by	radioimmunoassay.
Results and Discussion
Results	are	summarized	by	treatment	in	Table	1.	Progesterone	concentrations	did	not	differ	
between	treatments	at	PGF2α	injection	on	day	0	of	the	protocol	or	24	hours	before	timed	AI.	
Regression	of	the	CL	after	PGF2α	injection	on	day	0	did	not	differ	between	treatments	whether	
determined	by	visual	observation	of	the	CL	(monitored	by	transrectal	ultrasonography)	or	by	
changes	in	serum	progesterone	concentration.	Likewise,	estradiol	concentrations	did	not	differ	
between	treatments	at	PGF2α	injection	or	24	hours	before	timed	AI.	Incidences	of	single	or	
multiple	ovulations	in	response	to	the	first	or	second	GnRH	injection	did	not	differ	between	
treatments.	Volume	of	the	CL	on	day	9	was	not	different	between	treatments.	In	contrast,	the	
CL	volume	on	day	16	was	greater	(P	=	0.04)	for	cows	receiving	eCG	treatment,	but	concentra-
tions	of	progesterone	did	not	differ	between	treatments.	Cows	treated	with	eCG	tended		
(P	<	0.10)	to	have	an	increased	number	of	CL	on	day	9	and	16	(Table	1).
A	treatment	by	time	interaction	was	observed	for	estradiol	concentrations	during	the		
collection	period.	Concentrations	of	estradiol	gradually	increased	from	(eCG	=	2.45	vs.		
Control	=	2.68	pg/mL)	day	0	to	day	2	(4.24	vs.	4.0	pg/mL),	at	which	time	concentrations	
progressively	decreased	(2.0	vs.	2.0	pg/mL).	Estradiol	concentrations	did	not	differ	between	
treatments	from	days	0	to	3	(Figure	2).
Concentrations	of	progesterone	decreased	rapidly	from	days	0	to	2	after	the	injection	of	PGF2α	
administered	on	day	0.	Increased	progesterone	concentrations	from	days	2	to	4	are	the	result	
of	GnRH-induced	ovulation	of	a	preovulatory	follicle	and	subsequent	CL	formation.	Proges-
terone	concentrations,	however,	did	not	differ	between	treatments	from	days	0	to	4	after	eCG	
treatment.
Pregnancy	rates	did	not	differ	between	treatments	at	either	33	or	61	days	(Table	2).	Pregnancy	
loss	between	the	first	and	second	pregnancy	diagnoses	was	numerically	lesser	for	the	eCG	
treated	cows;	however,	no	significant	difference	was	detected	between	treatments.
Administration	of	eCG	failed	to	change	any	characteristic	studied	except	for	increased	luteal	
volume	by	day	16	postovulation.	Increased	luteal	volume	has	been	previously	observed	in	beef	
cattle	treated	at	similar	times	relative	to	AI.	Despite	increased	luteal	volume	by	day	16,	we	were	
unable	to	detect	an	increase	in	progesterone	concentration	as	reported	in	beef	cattle.
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Table 1. Effect of equine gonadotropin (eCG) on steroid concentrations, ovarian structures, and 
ovulation characteristics in lactating dairy cows
Treatment1
Item eCG Control P-value
Progesterone,	ng/mL
At	PGF2α 5.75	±	0.3 5.69	±	0.3 0.90
24	hours	before	AI 0.82	±	0.3 0.43	±	0.3 0.41
2	days	post-AI 0.63	±	0.3 0.79	±	0.3 0.73
CL	regression2
Visual,	% 97.0 94.0	 0.51
Based	on	changes	in	progesterone,	% 80.0 82.0	 0.89
Estradiol,	pg/mL
At	PGF2α 2.45	±	0.2 2.84	±	0.3 0.29
24	hours	before	AI 4.24	±	0.2 4.00	±	0.3 0.52
First	GnRH
Ovulation3,	% 63.6	±	0.5 69.1	±	0.5 0.52
Double	ovulation4,	% 21.4	±	0.4 19.0	±	0.4 0.86
Second	GnRH	
Ovulation5,	% 96.9	 100.0	 0.15
Double	ovulation6,	% 20.3	 18.2	 0.73
Ovulatory	follicle	diameter,	mm
Primary	follicle 13.9	±	0.3 15.0	±	0.48 0.08
Secondary	follicle 11.0	±	0.4 13.9	±	0.5 0.004
Corpora	lutea	(CL)	volume,	cm3
Day	9 6.57	±	0.5	 6.97	±	0.51 0.40
Day	16 9.1	±	0.5a 7.7	±	0.5b 0.04
CL	number
Day	9 1.3	±	0.05 1.2	±	0.06 0.08
Day	16 1.3	±	0.05 1.2	±	0.06 0.09
1	Ovulation	was	synchronized	using	Presynch	+	Ovsynch	with	or	without	400	IU	eCG	on	day	0.
2	Cows	with	luteal	regression	after	PGF2α	administration	on	day	0	as	determined	visually	(ultrasonography)	or	by	change	in	
serum	progesterone	concentrations.
3	Cows	ovulating	a	single	follicle	in	response	to	the	first	GnRH	injection	of	Ovsynch.
4	Cows	ovulating	more	than	1	follicle	in	response	to	first	GnRH	injection	of	Ovsynch.
5	Cows	ovulating	a	single	follicle	in	response	to	the	second	GnRH	injection	of	Ovsynch.
6	Cows	ovulating	more	than	1	follicle	in	response	to	second	GnRH	injection	of	Ovsynch.
Table 2. Effect of equine chorionic gonadotropin (eCG) on pregnancy rates and pregnancy loss 
in lactating dairy cows
Treatment1
Item eCG Control P-value
Pregnancy	rate	per	AI
At	33	days,	% 36.9 41.8 0.58
At	61	days,	% 32.3 32.3 0.96
Pregnancy	loss,	% 4.6 9.1 0.34
1	Ovulation	was	synchronized	using	Presynch	+	Ovsynch	with	or	without	400	IU	eCG	on	day	0.
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Figure 1. Experimental design. 
Treatments	for	Presynch	+	Ovsynch	timed	artificial	insemination	(AI)	protocol	with	or	without	admin-
istration	of	400	IU	equine	chorionic	gonadotropin	(eCG)	on	day	0.	PD	=	pregnancy	diagnosis	based	
on	visualization	of	viable	embryo;	P4	=	blood	sampling	and	analysis	of	progesterone	concentrations	in	
circulating	serum;	E	=	blood	sampling	and	analysis	of	estradiol	concentrations	in	circulating	serum;	U/S	
=	ultrasonography	of	the	ovaries	to	assess	size	and	changes	in	follicle	and	luteal	structures.
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Figure 2. Pattern of serum estradiol concentrations on days 0, 1, 2, and 3 of the study.
